Discovery of multi-target directed 3-OH pyrrolidine derivatives through a semisynthetic approach from alkaloid vasicine for the treatment of Alzheimer's disease-Reference-Cited by-同舟云学术

Discovery of multi-target directed 3-OH pyrrolidine derivatives through a semisynthetic approach from alkaloid vasicine for the treatment of Alzheimer's disease

Published:2023-03 Issue: Volume:249 Page:115145
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Bhanukiran Kancharla,T.A. Gajendra,Krishnamurthy Sairam,Singh Sushil Kumar,Hemalatha Siva^ORCID

Funder

Indian Institute of Technology Delhi

Indian Institute of Technology Madras

Ministry of Education, India

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference40 articles.

1. A review on Alzheimer's disease pathophysiology and its management: an update;Kumar;Pharmacol. Rep.,2015

2. Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent;Greig;Proc. Natl. Acad. Sci. U.S.A.,2005

3. Comprehensive review on Alzheimer's disease: causes and treatment;Breijyeh;Molecules,2020

4. Potent acetylcholinesterase inhibitors: potential drugs for Alzheimer's disease;Akıncıoğlu;Mini Rev. Med. Chem.,2020

5. In-vitro evaluation of selected Egyptian traditional herbal medicines for treatment of Alzheimer disease;Ali;BMC Compl. Alternative Med.,2013

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Affinity ultrafiltration based metabolomic profiling directed discovery novel butyrylcholinesterase inhibitors from Uncaria sessilifructus;International Journal of Biological Macromolecules;2024-10

2. Lead optimization based design, synthesis, and pharmacological evaluation of quinazoline derivatives as multi-targeting agents for Alzheimer's disease treatment;European Journal of Medicinal Chemistry;2024-05

3. Design, synthesis, and biological evaluation of some 2-(3-oxo-5,6-diphenyl-1,2,4-triazin-2(3H)-yl)-N-phenylacetamide hybrids as MTDLs for Alzheimer's disease therapy;European Journal of Medicinal Chemistry;2024-05

4. Single crystal X-ray, DFT, molecular dynamic simulations, and biological evaluation of 3-OH pyrrolidine derivative VA10 from alkaloid vasicine for BACE1 inhibition;Journal of Molecular Structure;2024-03

5. Design, synthesis, and biological evaluation of novel tryptanthrin derivatives as selective acetylcholinesterase inhibitors for the treatment of Alzheimer's disease;Bioorganic Chemistry;2024-02